Tag: Prescription Drugs
Diabetes Insipidus Can Occur After Stopping Vasopressin
Incidence may be underestimated due to a paucity of published reports, authors say
Long-Acting Erythropoiesis Agents Can Help Save Resources
Findings based upon time costs of preparation and administration per patient
Highest Adverse Effect Rates for Three Drugs in Parkinson’s
Incidence rates of dyskinesia were highest with ropinirole; also linked to high incidence of nausea
Naloxegol Has No Effect on Opioid Dose in Opioid-Tied Constipation
Centrally-mediated analgesia was maintained during treatment with naloxegol in noncancer pain, OIC
Anagliptin Effect on LDL in T2DM Via ApoB-100 Synthesis
Improvement appears mediated, at least in part, through suppression of apoB-100 synthesis
Half of Repeat Antibiotics in Australia Extend Initial Rx
More than one in five occur at least one month after the initial prescription
AAP: Epinephrine Admin Training Needed in Many Schools
In 2015 to 2016, 2.7 percent reported that epinephrine was administered by unlicensed staff
Physicians Tweeting About Drugs May Have Conflict of Interest
Physicians with financial conflict of interest often mention specific drugs for which they have a conflict
Sotagliflozin Linked to Improved Glycemic Control in T1DM
Primary end point achieved by more patients with type 1 diabetes receiving any insulin therapy
Exenatide Doesn’t Up Cardiovascular Risk in T2DM
Exenatide found to be non-inferior to placebo with respect to safety for patients with type 2 diabetes
